Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Invested Capital (2021 - 2025)

Oncology Institute (TOI) has disclosed Return on Invested Capital for 5 consecutive years, with 0.63% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital fell 7.0% year-over-year to 0.63%, compared with a TTM value of 0.63% through Sep 2025, down 7.0%, and an annual FY2023 reading of 0.44%, down 133.0% over the prior year.
  • Return on Invested Capital was 0.63% for Q3 2025 at Oncology Institute, up from 0.65% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.67% in Q4 2022 and bottomed at 1.64% in Q2 2022.
  • Average Return on Invested Capital over 5 years is 0.48%, with a median of 0.56% recorded in 2021.
  • The sharpest move saw Return on Invested Capital soared 122bps in 2022, then tumbled -118bps in 2023.
  • Year by year, Return on Invested Capital stood at 0.56% in 2021, then soared by 220bps to 0.67% in 2022, then crashed by -177bps to 0.51% in 2023, then decreased by -9bps to 0.56% in 2024, then fell by -13bps to 0.63% in 2025.
  • Business Quant data shows Return on Invested Capital for TOI at 0.63% in Q3 2025, 0.65% in Q2 2025, and 0.56% in Q3 2024.